The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 248.00
Bid: 247.50
Ask: 248.00
Change: 2.50 (1.02%)
Spread: 0.50 (0.202%)
Open: 247.00
High: 248.00
Low: 247.00
Prev. Close: 245.50
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Spire Healthcare Group PLC

1 Nov 2017 08:55

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings are being disclosed: York Capital Management Global Advisors, LLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Spire Healthcare Group PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: No
(e) Date position held/dealing undertaken: 31 October 2017
(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares

(ISIN: GB00BNLPYF73)

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled:
(2) Derivatives (other than options): 8,720,894 2.17%
(3) Options and agreements to purchase/sell:

TOTAL:

8,720,894 2.17%

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other executive options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit

(b) Derivatives transactions (other than options)

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit
Ordinary CFD Increasing a long position 111,000 2.9191 GBP

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercising

Class of relevant security Product description

e.g. call option

Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? No
Date of disclosure: 1 November 2017
Contact name: Adrian Jesuthasan
Telephone number: +44 2079075617

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

LEI: 213800IBJPW3SE2RA350

Classification: 3.1. Additional regulated information required to be disclosed under the laws of a Member State

View source version on businesswire.com: http://www.businesswire.com/news/home/20171101005783/en/

Copyright Business Wire 2017

Date   Source Headline
30th Jun 20215:21 pmRNSForm 8.3 - Spire Healthcare Group plc
30th Jun 20213:20 pmRNSForm 8.3 - Spire Healthcare Group plc
30th Jun 20212:48 pmEQSForm 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
30th Jun 202112:44 pmBUSFORM 8.3 - SPIRE HEALTHCARE GROUP PLC
30th Jun 202110:49 amRNSForm 8.5 (EPT/RI)-Spire Healthcare Group plc
30th Jun 202110:43 amRNSForm 8.3 - Spire Healthcare Group plc
30th Jun 20219:38 amRNSForm 8.5 (EPT/RI)
29th Jun 20215:27 pmRNSForm 8.3 - Spire Healthcare Group plc
29th Jun 20213:23 pmEQSForm 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
29th Jun 20213:20 pmRNSForm 8.3 -Spire Healthcare Group plc
29th Jun 202112:11 pmBUSFORM 8.3 - SPIRE HEALTHCARE GROUP PLC
29th Jun 202112:10 pmPRNForm 8.3 - Spire Healthcare Group Plc
29th Jun 202111:04 amRNSForm 8.5 (EPT/RI)-Spire Healthcare Group plc
29th Jun 202110:06 amRNSForm 8.5 (EPT/RI)
28th Jun 20215:28 pmRNSForm 8.3 - Spire Healthcare Group plc
28th Jun 20213:20 pmRNSForm 8.3 - Spire Healthcare Group plc
28th Jun 20213:20 pmRNSForm 8.3 - Spire Healthcare Group plc
28th Jun 20213:01 pmEQSForm 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
28th Jun 202112:15 pmPRNForm 8.3 - Spire Healthcare Group Plc
28th Jun 202112:05 pmBUSForm 8.3 - SPIRE HEALTHCARE GROUP PLC
28th Jun 202111:13 amRNSForm 8.5 (EPT/RI)-Spire Healthcare Group plc
28th Jun 20219:44 amRNSForm 8.5 (EPT/RI)
28th Jun 20219:00 amRNSUpdate on Court Meeting and General Meeting
25th Jun 20215:25 pmRNSForm 8.3 - Spire Healthcare Group plc
25th Jun 20213:20 pmRNSForm 8.3 - Spire Healthcare Group plc
25th Jun 20212:44 pmEQSForm 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
25th Jun 20211:52 pmPRNForm 8.3 - Spire Healthcare Group Plc
25th Jun 202112:49 pmBUSForm 8.3 - SPIRE HEALTHCARE GROUP PLC
25th Jun 202111:52 amRNSForm 8.3 - Spire Healthcare Group plc
25th Jun 202111:41 amRNSForm 8.5 (EPT/RI)
25th Jun 202110:48 amRNSForm 8.3 - Spire Healthcare Group plc
25th Jun 202110:37 amRNSForm 8.5 (EPT/RI)- Spire Healthcare Group plc
25th Jun 20219:01 amRNSForm 8.5 (EPT/RI) - Spire Healthcare Group Plc
25th Jun 20217:01 amRNSDirector Declaration
24th Jun 20215:21 pmRNSForm 8.3 - Spire Healthcare Group plc
24th Jun 20213:20 pmRNSForm 8.3 - Spire Healthcare Group plc
24th Jun 20213:11 pmEQSForm 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
24th Jun 20212:46 pmRNSForm 8.3 - Spire Healthcare Group plc
24th Jun 20212:28 pmBUSForm 8.3 - SPIRE HEALTHCARE GROUP PLC - Amendment
24th Jun 202112:55 pmBUSForm 8.3 - SPIRE HEALTHCARE GROUP PLC
24th Jun 202111:52 amPRNForm 8.3 - Spire Healthcare Group Plc
24th Jun 202111:29 amRNSForm 8.5 (EPT/RI)
24th Jun 202111:27 amRNSForm 8.5 (EPT/RI)- Spire Healthcare Group plc
24th Jun 202110:29 amRNSForm 8.5 (EPT/RI) - Spire Healthcare Group plc
24th Jun 20219:51 amRNSForm 8.3 - Spire Healthcare Group plc
23rd Jun 20216:15 pmRNSForm 8.5 (EPT/NON-RI)-Spire Healthcare grp plc amd
23rd Jun 20215:18 pmRNSForm 8.3 - Spire Healthcare Group plc
23rd Jun 20213:25 pmRNSForm 8.3 - Spire Healthcare Group plc
23rd Jun 20213:20 pmRNSForm 8.3 - Spire Healthcare Group plc
23rd Jun 20213:09 pmEQSForm 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.